Pain Management and Opioid Safety is Evolving Rapidly

The conversation around pain management and opioid safety is changing—and it needs to. While treatment models continue to evolve, one fact remains: 75% of patients do not take their medications correctly.

The result?

125,000 preventable deaths each year and $524 billion in added healthcare costs.

The Cost of Non-Adherence and Overdose

At the same time, 110,000 opioid overdose deaths occurred in 2023, costing our nation an estimated $2.7 trillion in medical expenses, unemployment, homelessness, and crime. And even though we have medications that reduce opioid overdose deaths by 50%, only 11% of patients can access them due to:

  • Transportation barriers
  • Childcare limitations
  • Stigma
  • Inequities and other social determinants of health

Meanwhile, opioid prescriptions have sharply declined—down 44% for acute pain and 40% for terminal cancer pain—leaving many patients suffering because providers, pharmacies, and manufacturers fear legal and regulatory repercussions.

We have reached a moral and ethical crossroads.

Patients deserve safe, effective pain treatment at home.

A New Path Forward

The iPill™ DISPENSER, developed by John Hsu, MD, and William Pedranti, JD, introduces a breakthrough solution designed to make home-based medication delivery safer, smarter, and more accountable.

The system provides:

  • Secure home delivery and biometric dispensing
  • Precise dosing only at prescribed times
  • Destruction of unused pills
  • Real-time adherence monitoring
  • Alerts to family and caregivers
  • EHR integration
  • Telehealth-based psychosocial support
  • Remote vital-sign capture via faceprint

This is medication management reimagined.

Clinical Trial Snapshot

To test the concept, six patients using Suboxone participated in a 30-day research study. Every participant successfully operated the iPill™ dispenser with no tampering, no emergency visits, and no additional provider interventions. Missed doses were quickly addressed through real-time alerts and family contact.

Even with a small sample size, the results were meaningful:

  • Secure biometric dispensing worked as intended
  • Medication adherence improved
  • Remote monitoring provided actionable clinical data
  • The system showed promise in reducing diversion and accidental overdose

Why This Matters

Human behavior is complex. But when technology provides structure, accountability, and real-time insight, we give patients a better chance at stability—and we give providers the tools they need to support safe pain and addiction care.

The iPill™ DISPENSER is not just a device.

It’s a pathway to safer prescribing, better monitoring, and more equitable access to lifesaving medications.

The future of pain management and opioid safety will be built on smarter systems like this one—and that future is getting closer.

About the Author

Nancy Low is a recognized expert in supporting Behavioral Health and Substance Use Disorder (SUD) providers and organizations. Through Wise Consulting Group, she offers education, training, and operational guidance to mental health and addiction treatment programs, including MAT, OBOT, residential, PHP/IOP, outpatient, and telehealth services.

iPill Technology